Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy
Tachycardia-induced cardiomyopathy is an entity characterized by reversible dysfunction of the left ventricle, which can be induced by different types of arrhythmia such as atrial fibrillation, atrial flutter, incessant supraventricular tachycardia and ventricular arrhythmia (more frequent causes)....
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2023-01-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://www.drugsincontext.com/emerging-concepts-in-heart-failure-management-and-treatment-focus-on-tachycardia-induced-cardiomyopathy |
| _version_ | 1828072325999755264 |
|---|---|
| author | María Victoria Báez Cabanillas Roberto Colque Miguel Ángel Tibaldi Edgardo Kaplinsky Sergio Perrone Alejandro Barbagelata |
| author_facet | María Victoria Báez Cabanillas Roberto Colque Miguel Ángel Tibaldi Edgardo Kaplinsky Sergio Perrone Alejandro Barbagelata |
| author_sort | María Victoria Báez Cabanillas |
| collection | DOAJ |
| description | Tachycardia-induced cardiomyopathy is an entity characterized by reversible dysfunction of the left ventricle, which can be induced by different types of arrhythmia such as atrial fibrillation, atrial flutter, incessant supraventricular tachycardia and ventricular arrhythmia (more frequent causes). Correct identification of the causative arrhythmia and normalization of the heart rate (e.g through medical treatment, electrical cardioversion, ablation) can lead to recovery of left ventricular function. Tachycardia-induced cardiomyopathy should be suspected in patients with tachycardia and left ventricular dysfunction (heart failure setting), especially when there is no history of previous heart disease. Its usual phenotype is that of non-ischaemic/non-valvular dilated cardiomyopathy and it can occur in both children (main cause: permanent junctional reciprocating tachycardia) and adults (main cause: atrial fibrillation). With proper treatment, most cases recover within a few months, though there is a risk of relapse, especially when the causal arrhythmia reappears or its control is lost. This is a narrative review that comprehensively addresses the pathophysiology, clinical manifestations, and therapeutic management of tachycardia-induced cardiomyopathy.
This article is part of the Emerging concepts in heart failure management and treatment Special Issue: https://www.drugsincontext.com/special_issues/emerging-concepts-in-heart-failure-management-and-treatment |
| first_indexed | 2024-04-11T01:08:41Z |
| format | Article |
| id | doaj.art-64187a438347478891d827d33c553cac |
| institution | Directory Open Access Journal |
| issn | 1740-4398 |
| language | English |
| last_indexed | 2024-04-11T01:08:41Z |
| publishDate | 2023-01-01 |
| publisher | BioExcel Publishing Ltd |
| record_format | Article |
| series | Drugs in Context |
| spelling | doaj.art-64187a438347478891d827d33c553cac2023-01-04T10:11:16ZengBioExcel Publishing LtdDrugs in Context1740-43982023-01-011211010.7573/dic.2022-8-4Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathyMaría Victoria Báez CabanillasRoberto ColqueMiguel Ángel TibaldiEdgardo KaplinskySergio PerroneAlejandro BarbagelataTachycardia-induced cardiomyopathy is an entity characterized by reversible dysfunction of the left ventricle, which can be induced by different types of arrhythmia such as atrial fibrillation, atrial flutter, incessant supraventricular tachycardia and ventricular arrhythmia (more frequent causes). Correct identification of the causative arrhythmia and normalization of the heart rate (e.g through medical treatment, electrical cardioversion, ablation) can lead to recovery of left ventricular function. Tachycardia-induced cardiomyopathy should be suspected in patients with tachycardia and left ventricular dysfunction (heart failure setting), especially when there is no history of previous heart disease. Its usual phenotype is that of non-ischaemic/non-valvular dilated cardiomyopathy and it can occur in both children (main cause: permanent junctional reciprocating tachycardia) and adults (main cause: atrial fibrillation). With proper treatment, most cases recover within a few months, though there is a risk of relapse, especially when the causal arrhythmia reappears or its control is lost. This is a narrative review that comprehensively addresses the pathophysiology, clinical manifestations, and therapeutic management of tachycardia-induced cardiomyopathy. This article is part of the Emerging concepts in heart failure management and treatment Special Issue: https://www.drugsincontext.com/special_issues/emerging-concepts-in-heart-failure-management-and-treatmenthttps://www.drugsincontext.com/emerging-concepts-in-heart-failure-management-and-treatment-focus-on-tachycardia-induced-cardiomyopathyatrial fibrillationcardiomyopathyheart failuretachyarrhythmiatachycardiatachycardiomyopathy |
| spellingShingle | María Victoria Báez Cabanillas Roberto Colque Miguel Ángel Tibaldi Edgardo Kaplinsky Sergio Perrone Alejandro Barbagelata Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy Drugs in Context atrial fibrillation cardiomyopathy heart failure tachyarrhythmia tachycardia tachycardiomyopathy |
| title | Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy |
| title_full | Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy |
| title_fullStr | Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy |
| title_full_unstemmed | Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy |
| title_short | Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathy |
| title_sort | emerging concepts in heart failure management and treatment focus on tachycardia induced cardiomyopathy |
| topic | atrial fibrillation cardiomyopathy heart failure tachyarrhythmia tachycardia tachycardiomyopathy |
| url | https://www.drugsincontext.com/emerging-concepts-in-heart-failure-management-and-treatment-focus-on-tachycardia-induced-cardiomyopathy |
| work_keys_str_mv | AT mariavictoriabaezcabanillas emergingconceptsinheartfailuremanagementandtreatmentfocusontachycardiainducedcardiomyopathy AT robertocolque emergingconceptsinheartfailuremanagementandtreatmentfocusontachycardiainducedcardiomyopathy AT miguelangeltibaldi emergingconceptsinheartfailuremanagementandtreatmentfocusontachycardiainducedcardiomyopathy AT edgardokaplinsky emergingconceptsinheartfailuremanagementandtreatmentfocusontachycardiainducedcardiomyopathy AT sergioperrone emergingconceptsinheartfailuremanagementandtreatmentfocusontachycardiainducedcardiomyopathy AT alejandrobarbagelata emergingconceptsinheartfailuremanagementandtreatmentfocusontachycardiainducedcardiomyopathy |